Strategic Healthcare Partnerships Sanguina collaborates with healthcare systems and insurers to generate biomarker driven datasets that help predict medical events and disease progression, creating sales opportunities with payers, hospital networks, and employer health programs seeking data driven remote monitoring and at home health management.

Regulatory Ready Entry The company has FDA clearance for AnemoCheck Home, signaling regulatory readiness for home testing in a patient centered remote monitoring strategy. This can enable clinics, home health providers, and maternal health programs to adopt Sanguina tools quickly, with opportunities to expand into additional use cases.

Innovation Ecosystem Funding Strategic investments from regional research institutes and tech partners validate the technology and open doors for co development pilots and grant funded initiatives with academic medical centers and payers.

Biomarker Data Edge Sanguina's platform uses proprietary biological data points and advanced image analysis to derive blood health biomarkers from fingernail characteristics, offering a unique data product for research organizations, pharma, and clinics seeking enhanced risk stratification and disease monitoring.

Global Access Growth The digital health approach expands blood health insights from underserved settings to patient homes worldwide, aligning with telehealth and remote patient monitoring trends and enabling scale through partnerships with healthcare systems and insurers.